Price T Rowe Associates Inc Legend Biotech Corp Call Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$265 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$116 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$106 Million0.02% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.24MShares$99.2 Million0.67% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.41B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...